Volume | 193,248 |
|
|||||
News | - | ||||||
Day High | 208.71 | Low High |
|||||
Day Low | 206.71 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Teleflex Inc | TFX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
208.55 | 206.71 | 208.71 | 208.29 | 209.30 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
6,162 | 193,248 | US$ 207.69 | US$ 40,135,689 | - | 177.633 - 262.97 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 35,187 | US$ 208.29 | USD |
Teleflex Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.8B | 47.06M | - | 2.98B | 356.33M | 7.57 | 27.51 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Teleflex News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 215.85 | 216.07 | 203.13 | 209.22 | 398,624 | -7.56 | -3.50% |
1 Month | 219.48 | 219.76 | 202.01 | 209.90 | 578,482 | -11.19 | -5.10% |
3 Months | 225.00 | 227.65 | 197.99 | 210.54 | 441,727 | -16.71 | -7.43% |
6 Months | 245.00 | 257.85 | 197.99 | 222.26 | 343,919 | -36.71 | -14.98% |
1 Year | 242.78 | 262.97 | 177.633 | 221.11 | 320,594 | -34.49 | -14.21% |
3 Years | 392.94 | 428.355 | 177.633 | 267.12 | 344,781 | -184.65 | -46.99% |
5 Years | 321.00 | 449.375 | 177.633 | 296.45 | 302,752 | -112.71 | -35.11% |
Teleflex Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |